Steven Isakoff, MD, PhD, MMSc, discusses data for invikafusp alfa plus sacituzumab govitecan in advanced HR-positive or triple-negative breast cancer.
Steven Isakoff, MD, PhD, MMSC
Advertisement
Articles by Steven Isakoff, MD, PhD, MMSC
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
VGX-3100 Elicits Regression and Clearance in HPV-16/18–Associated Cervical HSILs
2
EVX-01 Plus Pembrolizumab Yields Neoantigen-Specific T-Cell Responses in Advanced Melanoma
3
Canakinumab Reduces Nodule Size in High-Risk Lung Precancers
4
IDP-023 Plus Isatuximab Drives Responses in Daratumumab-Refractory Multiple Myeloma
5